Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFBS
1426
ServisFirst Bancshares
SFBS
$4.95B
| $3.28M | ﹤0.01% |
87,068
+1,400
| +2% | +$50K |
|
|
CSII
1427
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.28M | ﹤0.01% |
67,500
+2,200
| +3% | +$100K |
|
1428
HUB Group
HUBG
$2.46B
| $3.28M | ﹤0.01% |
127,800
| – | – |
|
|
CSGS
1429
DELISTED
CSG Systems International
CSGS
| $3.27M | ﹤0.01% |
63,200
+800
| +1% | +$43.2K |
|
1430
Mueller Industries
MLI
$15.1B
| $3.27M | ﹤0.01% |
412,000
+8,400
| +2% | +$64.3K |
|
1431
First Interstate BancSystem
FIBK
$3.7B
| $3.27M | ﹤0.01% |
77,983
+1,700
| +2% | +$71.3K |
|
|
VG
1432
DELISTED
Vonage Holdings Corporation
VG
| $3.25M | ﹤0.01% |
440,300
+6,900
| +2% | +$59.7K |
|
|
INVX
1433
Innovex International
INVX
$2.15B
| $3.25M | ﹤0.01% |
69,300
+1,200
| +2% | +$54.9K |
|
1434
Pacira BioSciences
PCRX
$924M
| $3.25M | ﹤0.01% |
71,700
+1,800
| +3% | +$76.5K |
|
1435
Cavco Industries
CVCO
$4.6B
| $3.24M | ﹤0.01% |
16,600
+300
| +2% | +$58.8K |
|
1436
InterDigital
IDCC
$9.07B
| $3.24M | ﹤0.01% |
59,500
| – | – |
|
1437
iRhythm Holdings
IRTC
$4.06B
| $3.24M | ﹤0.01% |
47,600
+1,300
| +3% | +$88.2K |
|
|
MINI
1438
DELISTED
Mobile Mini Inc
MINI
| $3.24M | ﹤0.01% |
85,500
+1,100
| +1% | +$41.5K |
|
|
DEA
1439
Easterly Government Properties
DEA
$1.16B
| $3.23M | ﹤0.01% |
54,524
+3,480
| +7% | +$196K |
|
1440
Red Rock Resorts
RRR
$3.73B
| $3.23M | ﹤0.01% |
134,700
+2,800
| +2% | +$62.3K |
|
1441
Northwest Bancshares
NWBI
$2.31B
| $3.23M | ﹤0.01% |
193,900
+4,600
| +2% | +$76.9K |
|
1442
Edgewell Personal Care
EPC
$1.32B
| $3.21M | ﹤0.01% |
103,600
+1,800
| +2% | +$58.1K |
|
1443
Core Laboratories
CLB
$571M
| $3.2M | ﹤0.01% |
84,900
+1,600
| +2% | +$71.9K |
|
1444
Axos Financial
AX
$5.68B
| $3.19M | ﹤0.01% |
105,400
+2,400
| +2% | +$70.1K |
|
1445
CNX Resources
CNX
$5.29B
| $3.19M | ﹤0.01% |
360,158
-6,600
| -2% | -$51.5K |
|
1446
CRISPR Therapeutics
CRSP
$5.22B
| $3.19M | ﹤0.01% |
52,300
+2,800
| +6% | +$153K |
|
1447
Hecla Mining
HL
$11.9B
| $3.18M | ﹤0.01% |
938,462
+26,100
| +3% | +$64K |
|
1448
Worthington Enterprises
WOR
$2.78B
| $3.17M | ﹤0.01% |
121,974
| – | – |
|
|
VNE
1449
DELISTED
Veoneer, Inc.
VNE
| $3.17M | ﹤0.01% |
202,600
+4,100
| +2% | +$66K |
|
|
KAMN
1450
DELISTED
Kaman Corp
KAMN
| $3.16M | ﹤0.01% |
48,000
+900
| +2% | +$56.2K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.